<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="24905">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02782533</url>
  </required_header>
  <id_info>
    <org_study_id>CHU Grenoble</org_study_id>
    <nct_id>NCT02782533</nct_id>
  </id_info>
  <brief_title>DBS of the Third Ventricle for Cluster Headache and Obesity</brief_title>
  <acronym>DBS V3</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Grenoble</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study of Deep Brain Stimulation of the Third ventricle in Cluster Headache and Obesity
      treatment.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2008</start_date>
  <completion_date type="Anticipated">November 2018</completion_date>
  <primary_completion_date type="Anticipated">November 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of Life Questionnaire</measure>
    <time_frame>weekly up to 3 years</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Cluster Headache</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>DBS V3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Deep Brain Stimulation V3</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Deep Brain Stimulation V3</intervention_name>
    <arm_group_label>DBS V3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria :

          -  Male or female aged between 18 and 65 years

          -  Ambulatory or hospitalized monitoring

          -  Fluent in French and able to understand the study procedures, including completing
             the auto-questionnaires

          -  Registered in the French social security scheme

          -  Signed informed consent of the patient will be collected before inclusion in the
             study

          -  Cluster Headache or Obesity patients

        Exclusion Criteria:

          -  Contraindication to Magnetoencephalography (MEG) and/or Electroencephalography (EEG)

          -  Contraindication to Magnetic resonance imaging (MRI)

          -  All categories of protected persons
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Stéphan CHABARDES, MD, PhD</last_name>
    <email>SChabardes@chu-grenoble.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Caroline Sandre-Ballester, PhD</last_name>
    <phone>+ 33 4 38 78 28 51</phone>
    <email>csandreballester@chu-grenoble.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CLINATEC</name>
      <address>
        <city>Grenoble</city>
        <zip>38000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stéphan CHABARDES, MD, PhD</last_name>
      <email>SChabardes@chu-grenoble.fr</email>
    </contact>
    <contact_backup>
      <last_name>Caroline Sandre-Ballester, PhD</last_name>
      <phone>+ 33 4 38 78 28 51</phone>
      <email>csandreballester@chu-grenoble.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Stéphan CHABARDES, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <lastchanged_date>January 17, 2017</lastchanged_date>
  <firstreceived_date>May 12, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Headache</mesh_term>
    <mesh_term>Cluster Headache</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
